| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Anaerobutyricum hallii co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Blautia obeum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Blautia obeum co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
| Coprococcus eutactus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Coprococcus eutactus co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4] |
| Eubacterium cellulosolvens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Eubacterium cellulosolvens co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4] |
| Eubacterium siraeum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Eubacterium siraeum co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4] |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Faecalibacterium prausnitzii co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4] |
| Lachnoclostridium phytofermentans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Lachnoclostridium phytofermentans co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4] |
| Lactobacillus acidophilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Lactobacillus acidophilus co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [5] |
| Ruminococcus albus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Ruminococcus albus co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4] |
| Bacteria: Fusobacteria |
| Fusobacterium mortiferum (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| M-7403 |
Click to Show/Hide the Detail |
| Drug ID |
DR2110
Drug Info
|
| Interaction Mechanism |
Human Sucrase-isomaltase intestinal (SI) and Fusobacterium mortiferum co-metabolize the drug M-7403, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6], [7] |
|
|
|
|
|
|